Abstract |
Immunomagnetic nanoparticles (IMNs) have been widely developed as a detection tool to isolate rare circulating tumor cells (CTCs) from whole blood as a potential method for early cancer diagnosis, metastasis examination, and treatment guidance. However, a spontaneous interaction between nanoparticles and proteins results in the formation of a protein corona that reduces the performance of IMNs when they enter body fluids. To address this issue, the protein corona was precoated onto magnetic nanoparticles (C-MNs), and then their surfaces were conjugated with an immuno-antibody. The adsorption of proteins on C-MNs was decreased 6-fold and non-specific cell binding was reduced 5-fold, compared with magnetic nanoparticles (MNs). Furthermore, the immuno-antibody functionalized C-MNs (IC-MNs) maintained highly specific CTC capture performance when exposed to blood plasma. By using artificial spiked blood samples, IC-MNs exhibited 90.2% CTC isolation efficiency, compared with 60.3% by using IMNs. IC-MNs also successfully captured CTCs with high purity in 24 out of 26 female breast cancer patient blood samples. This work demonstrated that a novel preformed protein corona strategy can provide a useful clinically applicable diagnostic tool.
|
Authors | Xinbang Jiang, Xiangyun Zhang, Chen Guo, Yameng Yu, Boya Ma, Zhuang Liu, Yamin Chai, Lichun Wang, Yunzheng Du, Biao Wang, Nan Li, Dong Dong, Yueguo Li, Xinglu Huang, Lailiang Ou |
Journal | Nanoscale
(Nanoscale)
Vol. 14
Issue 23
Pg. 8474-8483
(Jun 16 2022)
ISSN: 2040-3372 [Electronic] England |
PMID | 35661186
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Breast Neoplasms
(diagnosis, pathology)
- Cell Line, Tumor
- Cell Separation
- Female
- Humans
- Immunomagnetic Separation
(methods)
- Nanoparticles
- Neoplastic Cells, Circulating
(metabolism)
- Protein Corona
|